Header Logo

Connection

MICHAEL TAYLOR to DNA Methylation

Back to Details
This is a "connection" page, showing publications MICHAEL TAYLOR has written about DNA Methylation.
MICHAEL TAYLOR
Connection Strength
2.425
DNA Methylation
  1. The Amazing and Deadly Glioma Race. Cancer Cell. 2015 Sep 14; 28(3):275-7.
    View in: PubMed
    Score: 0.294
  2. Genome-wide methylation analysis. Methods Mol Biol. 2012; 863:303-17.
    View in: PubMed
    Score: 0.228
  3. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer. J Clin Invest. 2021 11 01; 131(21).
    View in: PubMed
    Score: 0.113
  4. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. J Clin Oncol. 2021 03 01; 39(7):807-821.
    View in: PubMed
    Score: 0.107
  5. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun. 2019 09 25; 10(1):4343.
    View in: PubMed
    Score: 0.097
  6. Bioinformatic Strategies for the Genomic and Epigenomic Characterization of Brain Tumors. Methods Mol Biol. 2019; 1869:37-56.
    View in: PubMed
    Score: 0.093
  7. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J Clin Invest. 2019 01 02; 129(1):223-229.
    View in: PubMed
    Score: 0.092
  8. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018 06; 19(6):785-798.
    View in: PubMed
    Score: 0.088
  9. DNA methylation-based classification of central nervous system tumours. Nature. 2018 03 22; 555(7697):469-474.
    View in: PubMed
    Score: 0.087
  10. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016 Feb 25; 164(5):1060-1072.
    View in: PubMed
    Score: 0.076
  11. Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups. Clin Cancer Res. 2015 Jan 01; 21(1):184-92.
    View in: PubMed
    Score: 0.069
  12. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature. 2014 Jun 26; 510(7506):537-41.
    View in: PubMed
    Score: 0.067
  13. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 2013 Jun; 125(6):913-6.
    View in: PubMed
    Score: 0.063
  14. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol. 2013 May; 14(6):534-42.
    View in: PubMed
    Score: 0.062
  15. Emerging insights into the ependymoma epigenome. Brain Pathol. 2013 Mar; 23(2):206-9.
    View in: PubMed
    Score: 0.062
  16. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol. 2013 Mar; 125(3):359-71.
    View in: PubMed
    Score: 0.061
  17. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature. 2012 Feb 15; 482(7386):529-33.
    View in: PubMed
    Score: 0.057
  18. The epigenetics of brain tumors. Methods Mol Biol. 2012; 863:139-53.
    View in: PubMed
    Score: 0.057
  19. PCDH10 is a candidate tumour suppressor gene in medulloblastoma. Childs Nerv Syst. 2011 Aug; 27(8):1243-9.
    View in: PubMed
    Score: 0.055
  20. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia. 2010 Jan; 12(1):20-7.
    View in: PubMed
    Score: 0.050
  21. 3D genome topology distinguishes molecular subgroups of medulloblastoma. Am J Hum Genet. 2024 Dec 05; 111(12):2720-2734.
    View in: PubMed
    Score: 0.035
  22. Spatial concordance of DNA methylation classification in diffuse glioma. Neuro Oncol. 2021 12 01; 23(12):2054-2065.
    View in: PubMed
    Score: 0.028
  23. Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma. Cell. 2020 06 11; 181(6):1329-1345.e24.
    View in: PubMed
    Score: 0.025
  24. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration. Cell Rep. 2019 11 19; 29(8):2338-2354.e7.
    View in: PubMed
    Score: 0.025
  25. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol. 2019 08; 138(2):309-326.
    View in: PubMed
    Score: 0.024
  26. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. Acta Neuropathol Commun. 2018 12 04; 6(1):134.
    View in: PubMed
    Score: 0.023
  27. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathol. 2018 08; 136(2):227-237.
    View in: PubMed
    Score: 0.022
  28. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathol. 2018 08; 136(2):211-226.
    View in: PubMed
    Score: 0.022
  29. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential. Acta Neuropathol Commun. 2018 06 07; 6(1):48.
    View in: PubMed
    Score: 0.022
  30. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma. Acta Neuropathol. 2018 04; 135(4):617-634.
    View in: PubMed
    Score: 0.022
  31. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma. Clin Cancer Res. 2018 03 15; 24(6):1355-1363.
    View in: PubMed
    Score: 0.022
  32. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas. Nat Commun. 2017 08 04; 8(1):186.
    View in: PubMed
    Score: 0.021
  33. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017 07 19; 547(7663):311-317.
    View in: PubMed
    Score: 0.021
  34. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017 06 12; 31(6):737-754.e6.
    View in: PubMed
    Score: 0.021
  35. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 2016 Dec 12; 30(6):891-908.
    View in: PubMed
    Score: 0.020
  36. Evasion of Cell Senescence Leads to Medulloblastoma Progression. Cell Rep. 2016 Mar 29; 14(12):2925-37.
    View in: PubMed
    Score: 0.019
  37. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. Cancer Cell. 2016 Mar 14; 29(3):394-406.
    View in: PubMed
    Score: 0.019
  38. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin. Cancer Cell. 2015 Dec 14; 28(6):715-729.
    View in: PubMed
    Score: 0.019
  39. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell. 2015 May 11; 27(5):728-43.
    View in: PubMed
    Score: 0.018
  40. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol. 2014 Aug; 128(2):291-303.
    View in: PubMed
    Score: 0.017
  41. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol. 2014 Jul; 128(1):137-49.
    View in: PubMed
    Score: 0.017
  42. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol. 2014 Aug; 128(2):279-89.
    View in: PubMed
    Score: 0.016
  43. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat Genet. 2014 Jan; 46(1):39-44.
    View in: PubMed
    Score: 0.016
  44. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012 Oct 16; 22(4):425-37.
    View in: PubMed
    Score: 0.015
  45. Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Cancer. 2012 Oct 15; 131(8):1800-9.
    View in: PubMed
    Score: 0.015
  46. International network of cancer genome projects. Nature. 2010 Apr 15; 464(7291):993-8.
    View in: PubMed
    Score: 0.013
  47. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res. 2008 Dec 01; 68(23):9945-53.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.